Kraft Heinz Affirms 2021 Adjusted EBITDA Outlook - Quick Facts

The Kraft Heinz Company (KHC) said, based on performance to date, it continues to expect to deliver 2021 adjusted EBITDA ahead of $6.1 billion. For 2022, the company expects to sustain stronger consumption versus pre-pandemic levels and maintain industry-leading margins.

Also, the company has increased price in approximately two thirds of its U.S. portfolio, and is prepared to take additional actions if input costs continue to rise.

CEO Miguel Patricio, said: "We are implementing necessary pricing actions to manage the
cost inflation we are currently seeing, including impacts likely to carry into
next year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT